OR WAIT 15 SECS
© 2021 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
February 24, 2021
Gene therapies to mitigate the effects of mutations that cause blindness are undergoing rapid development. Investigators have found that novel gene vectors reduce the risks associated with these procedures.
Treatment of patients with COVID-19 should include ophthalmic considerations.
February 23, 2021
Organization works to ensure clinical care and access for high-risk patients.
Dr. Bath could be the first African-American woman inducted into the Hall. As the first African-American woman to receive a medical patent, for the laserphaco probe, and the first woman to lead a post-graduate training program in ophthalmology, her experience is extensive.
February 22, 2021
The American Medical Association, American Hospital Association, American Nurses Association issued a sobering reality check as COVID-19 deaths in the United States passed the grim 500,000 milestone.
Findings from a new quality of life (QOL) assessment on thyroid eye disease (TED) indicate that the impact on patients extends well beyond its active phase and into the chronic phase.
Cataract surgeons must consider medication history as part of preoperative evaluation.
February 20, 2021
Arsham Sheybani, MD, offers insight on how his glaucoma patient management protocols have altered and the shift in subconjunctival surgery in light of the pandemic.
February 19, 2021
According to a study, ocular nodules have been found in the posterior pole and outside of the macular region in COVID-19 patients.
In this latest EyePod episode, John H. Merey, MD, possibly one of the last Holocaust survivors still in the practice of ophthalmology, shares his experience.